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Percutaneous renal biopsy is an essential tool for
establishing a diagnosis and managing various renal dis-
eases. Despite technical advances, this procedure is still
associated with postbiopsy complications. Among them,
bleeding is potentially the most serious complication [1].
At present, there is no worldwide standard or consensus
regarding how long patients need to be observed after
undergoing this procedure.
In order to monitor bleeding complications, many
institutions hospitalize patients for overnight observations
following percutaneous renal biopsy [2]. However, the
optimal duration for postbiopsy observation is still
controversial. While early studies have reported that short
observation periods are associated with missing 20–33% of
complications, recent studies report that most complica-
tions occur within 6–8 h after the procedure [1,3]. In this
regard, the prospective analyses by Park et al [4] are
favorable. They analyzed the incidence of bleeding com-
plications using serial postprocedure ultrasound and
blood and urine tests, concluding that 8 h of observation
is appropriate for some select patients [4].
Unfortunately, the study by Park et al did not enroll
patients who required an urgent renal biopsy. Patients
with acute renal failure or coagulation disorders might be
at higher risk of developing major bleeding complications.
Concerns about intermediate or late-onset complications
also remain unanswered because intrarenal arteriovenous
ﬁstula, pseudoaneurysm, renal infarction, or vascular
thromboembolism may occur [5]. Therefore, their results
cannot be extrapolated to all other patient groups who
might undergo a percutaneous renal biopsy [2].
It is difﬁcult to compare the specimen adequacy of the
study by Park et al to other studies because they did not aim
to assess the inﬂuence of biopsy needle size on the success
and complication rates of percutaneous renal biopsy.
Although there may be a beneﬁt to using large needles, we
must consider the increased risk of bleeding complications.
According to a few studies, larger needles can signiﬁcantly
increase the specimen adequacy without statistically affecting
the rate of bleeding complications [1].132/$ - see front matter
.1016/j.krcp.2012.01.003Irrespective of safety and efﬁcacy, the lower medical
cost is an important advantage for performing percuta-
neous renal biopsy as a daycare procedure. In Western
countries, patient hospitalization is a considerable ﬁnan-
cial burden. According to a study from the United King-
dom, the estimated cost of performing a biopsy as a
daycare procedure was £334, whereas an overnight stay
in hospital was estimated to cost £1618 [6]. This report
revealed that a signiﬁcant amount of money could be
saved by performing biopsies as a daycare procedure.
However, the situation would not be the same in every
country. Different strategies will need to be adopted by
different institutions, but performing percutaneous renal
biopsies as a daycare procedure is accepted as a modern
nephrology practice. An appropriate prebiopsy evaluation
should be required to avoid complications.
Sungjin Chung, Hye Eun Yoon, and Seok Joon Shin
Division of Nephrology, Department of Internal Medicine
Incheon St. Mary’s Hospital, The Catholic University
of Korea, 665, Bupyeoung 6-dong, Bupyeoung-gu Incheon,
403-720, Korea
E-mail address: imkidney@catholic.ac.krReferences
[1] Carrington CP, Williams A, Grifﬁths DF, Riley SG,
Donovan KL: Adult day-case renal biopsy: a single-centre
experience. Nephrol Dial Transplant. 26: 1559–1563,2011
[2] Maya ID, Allon M: Percutaneous renal biopsy: out-
patient observation without hospitalization is safe.
Semin Dial. 22:458–461, 2009
[3] Whittier WL, Korbet SM: Timing of complications in
percutaneous renal biopsy. J Am Soc Nephrol. 15:
142–147, 2004
[4] Park JY, Lee SW, Lee H, Park H, Koo HS, Lee HL, Sun HK,
Kim DK, Kim YS, Ahn C, Han JS, Kim S, Joo KW: How
long should we monitor the patient for bleeding
after percutaneous renal biopsy? Korean J Nephrol. 30:
475–483, 2011
Kidney Res Clin Pract 31 (2012) 83–8484[5] Chung S, Park CW, Chang YS: Renal infarction and
rapidly progressive arterial thromboembolism follow-
ing a percutaneous renal biopsy. BMJ Case Reports:
doi:10.1136/bcr.06.2009.1930, 2009
[6] Hussain F, Watson AR, Hayes J, Evans J: Standards for
renal biopsies: comparison of inpatient and day care
procedures. Pediatr Nephrol. 18:53–56, 2003
In Reply:
Dear Sir,
We appreciate your valuable comments regarding our
study. You raised several issues regarding our recent paper
[1], which explored the appropriate monitoring time required
after real-time ultrasound-guided percutaneous renal biopsy
(PRB). Their concerns are summarized as follows: (1) the
results of our study cannot be extrapolated to all patients
who might undergo PRB because patients with serious illness
were not enrolled in this study; (2) the specimen adequacy of
our study was not appropriately described; and (3) issues
regarding cost savings of daycare renal biopsy may not be
appropriate for some countries, such as Korea.
First, we enrolled 100 consecutive native kidney biop-
sies that were performed by two experienced nephrolo-
gists who did not classify these cases according to disease
severity. However, the patients who had deﬁnite bleeding
tendencies or uncontrolled hypertension were excluded.
Four patients with acute tubular necrosis were also
included in this study. As we mentioned in the discussion,
the appropriate patients for daycare renal biopsy are not
those who require urgent renal biopsy, but instead
patients who have a relatively low risk of complications.
In previous reports, selected patients were studied to
determine the effectiveness of daycare renal biopsy, and
the authors favored 8 h of observation time after PRB [2,3].
Thus, the appropriate patients for daycare renal biopsy are
not necessarily every patient who underwent PRB in
previously reported studies. Similarly, our results do not
need to be extrapolated to patients with serious illnesses.
We only described bleeding complications in this study,
but intermediate- and late-onset complications, such as
intrarenal arteriovenous ﬁstula, pseudoaneurysm, renal
infarction, and vascular thromboembolism, were not
detected on follow-up examinations.
Second, we did not mention specimen adequacy
because this study was not designed to assess theinﬂuence of biopsy needle size on the success or compli-
cation rates of PRB. Although we did not include data
regarding the number of glomeruli in each specimen, the
specimens were adequate for appropriate diagnosis in
each case. Thus, the 16-G needle that we used would be
appropriate for routine PRB.
Third, it may be true that in some developing countries
the cost savings of using PRB as a daycare procedure may
not be as much as in developed countries [4]. However, by
applying daycare renal biopsy to routine clinical practice,
we can be more ﬂexible when caring for patients with
variable conditions. The critical pathway (CP) for renal
biopsies has been operational at Seoul National University
Hospital since 2005. Renal biopsies are performed on the
day of admission, and the patient is discharged the next
day. We are considering whether renal biopsy CP can be
replaced by the daycare renal biopsy procedure in select
patients.Conﬂict of interest
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